Their characteristics include high IPS and active checkpoint expression, such as PD-1, CTLA4, TIME3 and LAG3. Referring to the association of UC metabolism with immune infiltration and immunotherapy, we attempted to use 14 UC metabolism-related genes to stratify colon cancer patients [6, 10, 11]. This evidence concerns the gene CTLA4 and malignant colon neoplasm.